FDA 483 - ARCH Medical Solutions - Warsaw - December 04, 2024

An inspection of ARCH Medical Solutions - Warsaw revealed significant deficiencies in their quality system. The firm failed to adequately establish and follow procedures for controlling nonconforming product, including dispositioning, rework, and scrap. Additionally, acceptance activities were not consistently documented, and procedures for routine equipment calibration were found to be inadequate.